Ech significantly reduced p-ERK1/2 levels in tumor tissues, while p-ERK1/2 levels in the model control group were not significantly altered (Figure 5(h)), suggesting that the in vivo antitumor mechanism of Ech was with respect to the inhibition of Raf/MEK/ERK signaling pathway. The gene discussed is MAP2K7; the disease is neoplasm.